课题基金 / 基金详情

DEFINITION OF FUNCTIONAL SITES ON COAGULATION FACTOR X

DEFINITION OF FUNCTIONAL SITES ON COAGULATION FACTOR X
凝血因子 X 功能位点的定义
批准号:
3471962
负责人:
William R Church
金额:
$10.97万
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-07-01 至 1994-06-30

项目摘要

项目成果

William R Church的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Both the intrinsic and extrinsic coagulation pathways terminate with the activation of the blood protein Factor X. Activated Factor X in turn forms a supramolecular complex, termed prothrombinase, consisting of an enzyme (Factor X alpha), a protein cofactor (Factor V alpha), calcium ion, and a phospholipid surface. This assembled complex catalyzes the proteolytic activation of prothrombin to the protease thrombin. The expedient formation of thrombin at wound sites thus requires the precise recognition and binding of the enzyme to a cofactor, a surface, and a substrate. Each of these interactions is mediated by distinct regions on the surface of Factor X. The approach outlined in this proposal will define those peptide sites on Factor X involved in recognition and binding to prothrombin, Factor V alpha, and phospholipid. The approach is to use isolated peptide fragments of Factor X, synthetic peptides from the known sequence of Factor X, and antibodies to specific topographic sites on Factor X in well- defined functional assays for Factor X. Peptides that will be synthesized include the variable region sequences of Factor X and sequences from the Gla domain. Several available monoclonal antibodies will be examined for their ability to inhibit Factor X activity and the antigenic determinant recognized by the inhibitory antibody alpha Beta F chi-2 beta will be localized. Antibodies produced to the synthetic peptides will also be examined for their ability to bind Factor X and to inhibit prothrombin activation, prothrombinase complex assembly or Factor X binding to phospholipid vesicles. This combined approach on the structure/function of Factor X using peptide fragments, synthetic peptides, and site- specific antibodies will provide more information about the relevant surface features of the Factor X molecule important for its function than would each approach used separately. Such topographic information will be extremely valuable in understanding the assembly, function, and regulation of prothrombinase, and at the same time, assist the design and modification of genetically engineered blood coagulation proteins.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DEFINITION OF FUNCTIONAL SITES ON COAGULATION FACTOR X
DEFINITION OF FUNCTIONAL SITES ON COAGULATION FACTOR X
DEFINITION OF FUNCTIONAL SITES ON COAGULATION FACTOR X
DEFINITION OF FUNCTIONAL SITES ON COAGULATION FACTOR X
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    王亚伟
  • 依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究